EP08.02-056. Coexisting MET Exon 14 Skipping Mutation and MET Amplification in a Patient with Complete Response to MET Inhibitors
Back to course
Pdf Summary
Asset Subtitle
Flávia Amaral Duarte
Meta Tag
Speaker Flávia Amaral Duarte
Topic Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
Keywords
non-small cell lung cancer
MET inhibitors
precision medicine
MET exon 14 skipping mutation
gene amplification of MET
tepotinib
lung adenocarcinoma
pembrolizumab
crizotinib
radiologic response
Powered By